相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Co-delivery of doxorubicin and SIS3 by folate-targeted polymeric micelles for overcoming tumor multidrug resistance
Shuanghu Wang et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2022)
Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease
Chander K. Negi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2022)
SIS3, a good candidate for the reverse of type 2 diabetes mellitus in mice
Dao-Cai Wang et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2021)
Effect of SIS3 on Extracellular Matrix Remodeling and Repair in a Lipopolysaccharide-Induced ARDS Rat Model
Qiong Liang et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
Progress and challenges in the prevention and control of nonalcoholic fatty liver disease
Jingjing Cai et al.
MEDICINAL RESEARCH REVIEWS (2019)
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2019)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
SIS3, a specific inhibitor of smad3, attenuates bleomycin-induced pulmonary fibrosis in mice
Juanjuan Shou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)
Krzysztof Tomasiewicz et al.
CLINICAL AND EXPERIMENTAL HEPATOLOGY (2018)
Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: Effects of statins and antidiabetic drugs
Niki Katsiki et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
Animal Models of Nonalcoholic Fatty Liver Disease-A Starter's Guide
Mikhail A. Van Herck et al.
NUTRIENTS (2017)
Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease
Alessandro Mantovani et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
Herbert Tilg et al.
HEPATOLOGY (2010)
Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-β1-induced extracellular matrix expression
M Jinnin et al.
MOLECULAR PHARMACOLOGY (2006)